Posts by: Ana Pamplona, PhD

Ana Pamplona, PhD

Ana holds her PhD in Biochemistry from the Faculty of Science and Technology from Lisbon (UNL). She has worked in the T-cell differentiation and Tumor targeting Lab at Instituto de Medicina Molecular, headed by Prof. Bruno Silva-Santos, and has served as a scientific reviewer for the peer-reviewed journal Infection & Immunity.

December 18, 2015December 19, 2015

Bacterial Infections Tied to COPD Flares May Be Determined Through Comorbidities

COPD, News

A new study found that the etiology of bacterial infections in acute exacerbations of chronic obstructive pulmonary disease could be determined through their associated comorbidities, a finding with relevance for clinical practice. ... Read more

December 16, 2015

Amoebas Helping COPD Researchers to Study Effects of Cigarette Smoke

COPD, News

A new experimental model — the social amoeba known as Dicty — may greatly help researchers understand the mechanism by which cells in airway passages protect themselves against cigarette smoke, and ... Read more

December 14, 2015December 14, 2015

FDA Approves Genentech’s ALECENSA as Oral Therapy for Advanced ALK-positive Non-small Cell Lung Cancer

Lung Cancer, News

ALECENSA (alectinib), a therapy commercialized by Genentech, was approved by U.S. Food and Drug Administration for the treatment of patients with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) previously ... Read more

December 11, 2015December 11, 2015

Pulmonary Cell Proliferation in PAH Triggered by RNA Fragments

News, Pulmonary Hypertension

In pulmonary hypertension, vascular remodeling due to excessive proliferation of endothelial and smooth muscle cells is a hallmark feature. Now, researchers have identified miR-125a as an important player in that remodeling. ... Read more

December 2, 2015December 2, 2015

COPD, Pulmonary Hypertension May Be Best Assessed by Chest Scan

News, Pulmonary Hypertension

Chest computed tomography could be a simple and useful method for diagnostic evaluation of COPD and pulmonary hypertension, according to a new study, “Computed tomography measurement of pulmonary artery for diagnosis ... Read more

December 1, 2015December 1, 2015

Cystic Fibrosis Study Finds a Mutated Protein Interacts in Damaging Ways

News

Researchers at The Scripps Research Institute recently found that the mutated cystic fibrosis transmembrane conductance regulator (CFTR) protein found in many cystic fibrorsis patients interacts with wrong neighboring proteins, and ... Read more

November 20, 2015November 20, 2015

Teva’s Novel Multidose Dry Powder Inhalers Reveal Positive Outcomes for Asthma Patients

Asthma, News

Teva Pharmaceutical Industries Ltd. announced positive top-line results from Phase III trials that tested the efficacy and safety of fluticasone propionate/salmeterol and fluticasone propionate multidose dry powder inhalers (MDPIs) in adolescent and ... Read more

November 19, 2015

Cystic Fibrosis Study Explores Steps in Intestinal Inflammation

Cystic Fibrosis

A new study revealed that the cystic fibrosis transmembrane conductance regulator (CFTR) plays an important role in regulating intestinal inflammatory responses. The study, entitled “CFTR Knockdown induces pro inflammatory changes ... Read more

November 17, 2015November 18, 2015

Proper Asthma Diagnosis Still Challenging for Physicians

Asthma, News

A new study suggests that large numbers of asthma patients in Italy are still being under-diagnosed or misdiagnosed some 20 years after the dissemination of the Global Initiative for Asthma guidelines to ... Read more

November 11, 2015November 11, 2015

New Study Calls Attention to Common Use of Antibiotics for Viral Acute Respiratory Tract Infections

Chronic Bronchitis, News

A new study entitled “Antibiotic Use for Viral Acute Respiratory Tract Infections Remains Common,” recently published in The American Journal of Managed Care, calls clinicians’ and patients’ attention to unintentional adverse ... Read more